GlassScriptPhysician profile
Ketan G Kulkarni
NPI 1710994231
$6,650.06
in general payments reported to CMS, 2019-2025
34 companies · $1,644 in 2025
The $1,644 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $794 · 2020: $215 · 2021: $241 · 2022: $843 · 2023: $1,280 · 2024: $1,633 · 2025: $1,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,515 · Education: $41.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,515.29 |
| Education | $41.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,091.79 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $646.62 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $621.74 | 2019-2025 | Xifaxan, Plenvu |
| Janssen Biotech, INC. | $472.49 | 2019-2025 | Tremfya, Stelara |
| Boston Scientific Corporation | $327.69 | 2023-2025 | Exalt Model D |
| Pfizer INC. | $327.35 | 2019-2025 | |
| Celgene Corporation | $270.73 | 2021-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $260.63 | 2022-2025 | Dupixent |
| Lilly USA, LLC | $195.90 | 2024-2025 | Omvoh |
| Jazz Pharmaceuticals INC. | $127.52 | 2024 | |
| Genzyme Corporation | $127.29 | 2023-2025 | |
| Celltrion USA INC. | $116.81 | 2024-2025 | Vegzelma, Zymfentra |
| Gilead Sciences, INC. | $101.01 | 2021-2025 | |
| Shionogi INC | $97.42 | 2019 | |
| Ardelyx, INC. | $94.61 | 2023-2025 | Ibsrela |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $79.93 | 2024 | Resmetirom |
| Novo Nordisk INC | $78.28 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $76.68 | 2019-2024 | Dificid |
| Qol Medical, LLC | $63.54 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $61.65 | 2025 | Terlivaz |
| Intercept Pharmaceuticals, INC. | $49.87 | 2021-2022 | |
| Amgen INC. | $39.51 | 2020-2023 | Amjevita |
| Apollo Endosurgery US INC | $39.04 | 2022 | |
| Phathom Pharmaceuticals, INC. | $36.33 | 2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $34.34 | 2020-2022 | |
| Nestle Healthcare Nutrition INC. | $33.99 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $33.15 | 2022 | |
| Aimmune Therapeutics, INC. | $30.68 | 2024-2025 | Zenpep |
| Ferring Pharmaceuticals INC. | $29.04 | 2023 | Rebyota |
| Exact Sciences Corporation | $24.54 | 2023 | Cologuard Collection Kit |
| Ipsen Biopharmaceuticals, INC | $18.63 | 2024 | Iqirvo |
| Ucb, INC. | $16.34 | 2019 | |
| Fresenius Kabi USA, LLC | $13.85 | 2023 | |
| Evoke Pharma, INC. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ketan Kulkarni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.